Analyzing Stock On Your Own: Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)

Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) does about 3.09M shares in volume on a normal day but saw 2496659 shares change hands in Monday trading. The company now has a market cap of 962.72M USD. Its current market price is $4.67, marking a decrease of -2.10% compared to the previous close of $4.77. The 52 week high […]

Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) – Time For Strategy Change?

Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) currently has a daily average trading volume of 3.08M but it saw 3304086 shares traded in last market. With a market cap of 1.05B USD, the company’s current market price of $5.10 came rising about 4.72 while comparing to the previous closing price of $4.87. In past 52 weeks, the stock […]

Can Buying Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Still Be Worthwhile?

Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) does about 3.31M shares in volume on a normal day but saw 3481528 shares change hands in Thursday’s trading. The company now has a market cap of 1.05B USD. Its current market price is $5.08, marking a decrease of -1.36% compared to the previous close of $5.15. The 52 week high […]

Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) – Time For Strategy Change?

Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) currently has a daily average trading volume of 3.30M but it saw 2625398 shares traded in last market. With a market cap of 1.13B USD, the company’s current market price of $5.49 came rising about 0.37 while comparing to the previous closing price of $5.47. In past 52 weeks, the stock […]